Skip to content
DraconiticResearch
Search Sources API
194,161 studies31 sourcesUpdated 6 min ago
PreprintAll rights reservedbioRxiv

Development of a nanomedicine approach to improve the therapeutic index of bexarotene.

  1. 1Cardiff University

Related

  1. Chitosan nanoparticles functionalised with protocatechuic acid improve colon-targeted pazopanib delivery with multi-pathway therapeutic regulation and pharmacokinetic optimisation in colorectal cancer
    Tanvi Maheshwari, Sankha Bhattacharya
    CytotechnologyPeer-reviewedLicence not statedFull textPharmacology & toxicologyPMC
  2. Cholesterol-Mediated Modulation of Collecting Lymphatic Vessel Contractility: Exploring Cholesterol Depletion as a Therapeutic Alternative to Improve Lymphatic Function in Hypercholesterolemia
    K. Keane, J. A. Castorena-Gonzalez
    bioRxivPreprintAll rights reservedFull textPhysiologybioRxiv
  3. From digital reminders to artificial intelligence–enabled understanding: can personalized treatment predictions improve therapeutic adherence?
    Valentin Goutaudier, Jean-Sébastien Hulot
    European Heart Journal. Cardiovascular PharmacotherapyPeer-reviewedCC BY 4.0Full text1 citedCardiovascular medicinePMC
  4. Tarloxotinib targets tumor hypoxia to improve therapeutic efficacy of immune checkpoint inhibition in a MyD88-dependent manner.
    Zhe Fu, Victoria Jackson-Patel, Kathryn Farrand +7
    Journal for immunotherapy of cancerPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  5. Culturally adapted home-based intervention to improve child’s development in Arab toddlers in Israel: study protocol for a randomized controlled trial
    Niveen Omar, Michael Davidovitch, Hazar Zahalka +2
    TrialsPeer-reviewedCC BY-NC-ND 4.0Clinical trials & evidence synthesisCrossref
BibTeX
@misc{rizzo2026development,
  title = {{Development of a nanomedicine approach to improve the therapeutic index of bexarotene.}},
  author = {S. Rizzo and C. Pepe and T. Albert and G. Braux and T. Cahart and C. Varicchio and T. Robertshaw and T. R. Hughes and Y. Zhou and E. L. Ferguson},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.05.756654},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.05.756654v1},
}
RIS
TY  - UNPB
TI  - Development of a nanomedicine approach to improve the therapeutic index of bexarotene.
AU  - S. Rizzo
AU  - C. Pepe
AU  - T. Albert
AU  - G. Braux
AU  - T. Cahart
AU  - C. Varicchio
AU  - T. Robertshaw
AU  - T. R. Hughes
AU  - Y. Zhou
AU  - E. L. Ferguson
PY  - 2026
DA  - 2026/10/05
PB  - bioRxiv
DO  - 10.64898/2026.10.05.756654
UR  - https://www.biorxiv.org/content/10.64898/2026.10.05.756654v1
ER  -